Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,075 | 8,841 | 9,763 | 11,121 | 2 |
| Receivables | N/A | 425 | 199 | 38 | 735 |
| TOTAL | $8,119 | $9,402 | $10,201 | $11,441 | $748 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 370 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $370 |
| Total Assets | $8,119 | $9,402 | $10,201 | $11,441 | $1,117 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 342 | 140 | 124 | 55 | 1,234 |
| Accrued Expenses | 237 | 141 | 579 | 695 | 777 |
| TOTAL | $578 | $281 | $703 | $749 | $2,011 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 7,577 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $7,683 |
| Total Liabilities | $578 | $281 | $703 | $749 | $9,694 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,947 | 6,892 | 6,867 | 6,860 | N/A |
| Common Shares | 1 | 1 | 1 | 1 | 0 |
| Retained earnings | -14,239 | -12,535 | -11,528 | -9,219 | -8,777 |
| TOTAL | $7,541 | $9,121 | $9,498 | $10,692 | $-8,576 |
| Total Liabilities And Equity | $8,119 | $9,402 | $10,201 | $11,441 | $1,117 |